IRX 010
Alternative Names: IRX-010Latest Information Update: 23 Apr 2024
At a glance
- Originator ImmunoRx Pharma
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase I Unspecified
Most Recent Events
- 07 Jun 2023 Phase-I clinical trials in Unspecified (In volunteers) in Netherlands (IV) (NCT06356259)